Skip to content

Serotyping and antimicrobial susceptibility testing of Salmonella enterica in 2021

Serotyping and antimicrobial susceptibility testing of Salmonella enterica in 2021

The information is for S. enterica culture isolates received during the designated year.

Serotypic name No. tested Sterile site specimens Non-sterile site specimens
Total Not susceptible % Total Not susceptible %
Ciprofloxacin Ceftriaxone Ciprofloxacin Ceftriaxone
Enteritidis 718 150 57.3% 8.7% 568 57.7% 3.5%
I 4:i:- 461 12 41.7% 8.3% 449 36.5% 15.4%
Typhimurium 120 5 0.0%
20.0% 115 76.5% 11.3%
Rissen 67 3 33.3% 0.0% 64 28.1% 0.0%
London 41 0 - - 41 43.9% 29.3%
Derby 38 2 50.0% 0.0% 36 52.8% 0.0%
Saintpaul 22 1 0.0% 0.0% 21 85.7% 4.8%
Goldcoast 13 0 - - 13 46.2% 0.0%
Typhi 6 6 50.0% 0.0% 0 - -
Braenderup 8 0 - - 8 50.0% 0.0%
Wandsworth 5 1 100.0% 0.0% 4 100.0% 0.0%
Stanley 59 2 50.0% 0.0% 57 15.8% 0.0%
Bareilly 16 1 0.0% 0.0% 15 33.3% 0.0%
Meleagridis 3 0 - - 3 0.0% 0.0%
Weltevreden 25 0 - - 25 20.0% 0.0%
I 19:g,s,t 2 0 - - 2 0.0% 0.0%
Give 1 0 - - 1 0.0% 0.0%
Singapore 5 0 - - 5 60.0% 0.0%
Reading 0 0 - - 0 - -
Kentucky 9 2 100.0% 100.0% 7 100.0% 71.4%
Others 142 18 33.3% 22.2% 124 36.3% 6.5%


Remarks:

Multiple strains may have been received from the same patient.